Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | R3047* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM R3047* results in a premature truncation of the Atm protein at amino acid 3047 of 3056 (UniProt.org). R3047* results in a loss of reactive oxygen species-induced phosphorylation of Atm and downstream targets (PMID: 20966255), but demonstrates conflicting effects on DNA-damage induced ATM activation as indicated by loss of Atm and phosphorylation of downstream targets in response to ionizing irradiation in culture (PMID: 19431188), while resulting in Tp53 phosphorylation in response to MRN complex in an in vitro assay and Atm phosphorylation upon camptothecin treatment in patient cell culture (PMID: 20966255), and therefore, is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM R3047* |
Transcript | NM_000051.4 |
gDNA | chr11:g.108365476C>T |
cDNA | c.9139C>T |
Protein | p.R3047* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001351834.1 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108365476C>T | c.9139C>T | p.R3047* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|